Robert Andrade is CFO at FENNEC PHARMACEUTICALS INC. (FENC). They have made 2 open-market trades across 1 company since 2022, most recently 2026-10-12.
CIK 0001468308
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FENC | 246,855 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2026-10-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FENC | SELL · 10b5-1 | 2026-08-27 | 2026-08-28 | $11.78 | $884K | -8.6% | -11.3% | — |
| FENC | SELL | 2024-03-26 | 2024-03-27 | $10.90 | $305K | -2.8% | -17.8% | -44.6% |
| FENC | SELL · 10b5-1 | 2024-03-25 | 2024-03-25 | $11.00 | $154K | -2.6% | -17.3% | -42.1% |
| FENC | SELL · 10b5-1 | 2024-01-04 | 2024-01-05 | $10.53 | $316K | -1.2% | -4.4% | +6.5% |
| FENC | SELL · 10b5-1 | 2023-06-28 | 2023-06-30 | $8.93 | $223K | +1.1% | +1.8% | -18.3% |
| FENC | SELL | 2022-12-28 | 2022-12-30 | $9.60 | $211K | +3.0% | -3.4% | -12.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.